# A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects

> **NCT02070510** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 52 (actual)

## Conditions studied

- Diabetes
- Healthy

## Interventions

- **DRUG:** semaglutide
- **DRUG:** lisinopril
- **DRUG:** warfarin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02070510
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-27
- **Primary completion:** 2014-08-20
- **Final completion:** 2014-08-20
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2020-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02070510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02070510, "A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02070510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*